Nonclinical scientists in drug development have volumes of data to analyze and interpret. Visualization is a key tool in their toolbox, allowing for the detection of signals and outliers. SEND datasets are ideal for powering these visualizations. Learn how to turn this regulatory dataset into a engine for internal decision-making with SEND Explorer.
Compared to the Phoenix software installed on local computers, Phoenix Hosted gives research teams much better application performance, flexible access from PC or Mac environments, and comes pre-installed, pre-licensed, and pre-validated. Phoenix Hosted offers scalable hardware to any number of users in a personal workspace for each user. Teams can quickly adopt the latest version … Continued
When a pharmaceutical company faces the end of a product’s patent life, it encounters a myriad of challenges, including the need to overhaul its marketing and sales strategies. This session delves deep into these challenges, emphasizing how companies can pivot towards enhancing the marketing of their existing, patented products. The webinar will provide insights into … Continued
PK analysis intended for submission contends with many data and compliance challenges. To work efficiently, analysts need a method and toolset that: Join us to explore a workflow that offers these benefits in a secure, cloud-hosted environment. We’ll follow a non-compartmental analysis from end-to-end to highlight best practices for data preparation, modeling, and submission readiness. … Continued
Topics covered: Speakers: Gilbert HunterCustomer Success ManagerPinnacle 21 by Certara Erin ErginerDirector of ProductPinnacle 21 by Certara
What does it take to industrialize QSP? What is the right mix of technology and domain expertise to integrate at scale? Join Certara’s Piet van der Graaf, formerly Applied BioMath’s John Burke and Joshua Apgar for insightful and interactive webinar as we share details of our vision for the next generation of QSP. Hear about … Continued
Master clinical phase transitions with insights from industry leaders! Join Piet van der Graaf, SVP and Head of QSP, Hugo Geerts, Head of Neuroscience Modeling QSP, Mirjam Trame, VP of Certara Drug Development Solutions, and Julie M. Bullock, PharmD, SVP of Drug Development Services at Certara. We are thrilled to welcome keynote speaker and panelist … Continued
Secondary pharmacology profiling involves the screening of small molecule compounds against a broad range of targets in order to try to predict off-target interactions leading to safety issues in humans. To date, this has generally required an opinion-based approach, but opinions vary and are inherently unreliable. To evaluate this quantitatively requires the use of surrogate … Continued
As regulatory acceptance of models for decision-making grows, so too does the need for optimally fit models, free as possible from human bias. This places high demands on the modeling workbench, which must build and fine-tuning thousands of models across a vast search space, then select a winner according to standard goodness-of-fit and custom criteria. … Continued
Advanced Strategies and Best Practices for Predictive Pharmacokinetics using Simcyp™ Discovery Refine your approach to early drug development with insights from industry experts in our upcoming webinar, “First-In-Human (FIH) Faster: The Power of Physiologically Based Pharmacokinetic Modeling (PBPK).” If you’re seeking strategies to identify and advance your small molecule drug candidates, expedite product profiling, formulation, … Continued
